Literature DB >> 26559563

Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells.

W Schlörmann1, S Naumann2, C Renner2, M Glei2.   

Abstract

Epigenetic and posttranslational modifications of the expression of cell cycle-relevant genes or proteins like p21, e.g., by miRNAs are crucial mechanisms in the development or prevention of colon cancer. The present study investigated the influence of butyrate and trichostatin A (TSA) as histone deacetylase inhibitors on the expression of colon cancer-relevant miRNA (miR-135a, miR-135b, miR-24, miR-106b, miR-let-7a) in LT97 colon adenoma cells as a model of an early stage of colon carcinogenesis. The impact of distinct miRNAs (miR-106b, miR-135a) on butyrate-mediated regulation of p21 and Cyclin D2 gene and protein expression as well as the effect on LT97 cell proliferation (non-transfected, miR-106b and miR-135a mimic transfected) was analyzed. Butyrate and partial TSA reduced the expression of miR-135a, miR-135b, miR-24 and miR-let-7a (~0.5-fold, 24 h) and miR-24, miR-106b and miR-let-7a (~0.5-0.7-fold, 48 h) in LT97 cells. Levels of p21 mRNA and protein were significantly increased by butyrate and TSA (~threefold and 4.5-fold, respectively, 24 h) in non-transfected but not in miR-106b transfected LT97 cells. Levels of Cyclin D2 mRNA were significantly reduced by butyrate and TSA (~0.3-fold, 24 h) in non-transfected and miR-135a-transfected LT97 cells, whereas protein levels were predominantly not influenced. MiR-106b and miR-135a significantly reduced butyrate-/TSA-mediated inhibition of LT97 cell proliferation (72 h). These results indicate that butyrate is able to modify colon cancer-relevant miRNAs like miR-106b and miR-135a which are involved in the regulation of cell cycle-relevant genes like p21 and might influence inhibition of adenoma cell proliferation.

Entities:  

Keywords:  Cell cycle; Colon cancer; Epigenetic; Histone deacetylase inhibitor; LT97 cells

Year:  2015        PMID: 26559563      PMCID: PMC4642459          DOI: 10.1007/s12263-015-0500-4

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  45 in total

1.  The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma (LT97) than tumor (HT29) cells.

Authors:  Tanja Kautenburger; Gabriele Beyer-Sehlmeyer; Grit Festag; Natja Haag; Stephanie Kühler; Alma Küchler; Anja Weise; Brigitte Marian; Wilbert H M Peters; Thomas Liehr; Uwe Claussen; Beatrice L Pool-Zobel
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

2.  The human colonic monocarboxylate transporter Isoform 1: its potential importance to colonic tissue homeostasis.

Authors:  Mark Cuff; Jane Dyer; Mark Jones; Soraya Shirazi-Beechey
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

3.  The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.

Authors:  Brian F Hinnebusch; Shufen Meng; James T Wu; Sonia Y Archer; Richard A Hodin
Journal:  J Nutr       Date:  2002-05       Impact factor: 4.798

4.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Tomoki Naoe
Journal:  Biol Pharm Bull       Date:  2006-05       Impact factor: 2.233

5.  Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study.

Authors:  Sheila A Bingham; Nicholas E Day; Robert Luben; Pietro Ferrari; Nadia Slimani; Teresa Norat; Françoise Clavel-Chapelon; Emmanuelle Kesse; Alexandra Nieters; Heiner Boeing; Anne Tjønneland; Kim Overvad; Carmen Martinez; Miren Dorronsoro; Carlos A Gonzalez; Timothy J Key; Antonia Trichopoulou; Androniki Naska; Paolo Vineis; Rosario Tumino; Vittorio Krogh; H Bas Bueno-de-Mesquita; Petra H M Peeters; Göran Berglund; Göran Hallmans; Eiliv Lund; Guri Skeie; Rudolf Kaaks; Elio Riboli
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

6.  Influence of inorganic and organic iron compounds on parameters of cell growth and survival in human colon cells.

Authors:  Stefanie Klenow; Beatrice L Pool-Zobel; Michael Glei
Journal:  Toxicol In Vitro       Date:  2009-04       Impact factor: 3.500

7.  Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro.

Authors:  M Richter; D Jurek; F Wrba; K Kaserer; G Wurzer; J Karner-Hanusch; B Marian
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

8.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.

Authors:  A Mermelshtein; A Gerson; S Walfisch; B Delgado; G Shechter-Maor; J Delgado; A Fich; L Gheber
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640

View more
  14 in total

1.  miR-526b-3p functions as a tumor suppressor in colon cancer by regulating HIF-1α.

Authors:  Rui Zhang; Jian Zhao; Jian Xu; Jian Wang; Jianhui Jia
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 2.  microRNA-Mediated Tumor-Microbiota Metabolic Interactions in Colorectal Cancer.

Authors:  Ce Yuan; Subbaya Subramanian
Journal:  DNA Cell Biol       Date:  2019-01-22       Impact factor: 3.311

3.  Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice.

Authors:  Noreen McBrearty; Alla Arzumanyan; Eugene Bichenkov; Salim Merali; Carmen Merali; Mark Feitelson
Journal:  Neoplasia       Date:  2021-05-01       Impact factor: 5.715

4.  A Prebiotic Formula Improves the Gastrointestinal Bacterial Flora in Toddlers.

Authors:  Ya-Ling Chen; Fang-Hsuean Liao; Shyh-Hsiang Lin; Yi-Wen Chien
Journal:  Gastroenterol Res Pract       Date:  2016-06-14       Impact factor: 2.260

5.  Chemopreventive Potential of Raw and Roasted Pistachios Regarding Colon Carcinogenesis.

Authors:  Michael Glei; Diana Ludwig; Julia Lamberty; Sonja Fischer; Stefan Lorkowski; Wiebke Schlörmann
Journal:  Nutrients       Date:  2017-12-18       Impact factor: 5.717

6.  Non-digestible carbohydrates supplementation increases miR-32 expression in the healthy human colorectal epithelium: A randomized controlled trial.

Authors:  Fiona C Malcomson; Naomi D Willis; Iain McCallum; Long Xie; Bart Lagerwaard; Seamus Kelly; D Michael Bradburn; Nigel J Belshaw; Ian T Johnson; John C Mathers
Journal:  Mol Carcinog       Date:  2017-05-09       Impact factor: 4.784

7.  Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT.

Authors:  Zhiming Zheng; Yongchao Zhang; Zhen Zhang; Yihang Yang; Tao Song
Journal:  Med Sci Monit       Date:  2017-03-13

Review 8.  Non-coding RNA/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins.

Authors:  Bernhard Biersack
Journal:  Noncoding RNA Res       Date:  2016-09-03

Review 9.  Epigenetic Regulation of Gene Expression Induced by Butyrate in Colorectal Cancer: Involvement of MicroRNA.

Authors:  Karen S Bishop; Huawen Xu; Gareth Marlow
Journal:  Genet Epigenet       Date:  2017-09-25

Review 10.  Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities.

Authors:  Alessandro Allegra; Caterina Musolino; Alessandro Tonacci; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.